Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Routine vs Intensive Methimazole Treatment for Graves' Disease
NCT05461820Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methimazole in Graves' disease, sponsored by Jiangsu Provincial People's Hospital. Started May 2018; status: recruiting.
02
Drugs
methimazole
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT05461820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461820.